title: [Neoadjuvant and adjuvant therapies for solid tumours].
abstract: Today adjuvant or neoadjuvant therapies are standard treatment for many types of cancer. Chemotherapy, radiotherapy, hormone therapy or immunotherapy applied before, during or after an operation can lower the risk of relapse and hence, increase the chances of a cure. After neoadjuvant therapy, frequently the organ does not have to be removed in the subsequent operation. Depending on the risk of relapse, adjuvant therapies are employed after due consideration of benefit, risk and duration of treatment. In ongoing clinical studies, the possibilities of influencing the effect of epidermal growth factor (EGF) as well as vascular endothelial growth factor (VEGF) are being investigated.
authors.affiliation: Medizinische Klinik und Poliklinik III, Klinikum Grosshadern LMU München. Volker.Heinemann@med.uni-muenchen.de
authors.forename: Volker
authors.initials: V
authors.lastname: Heinemann
authors.forename: Nicolas
authors.initials: N
authors.lastname: Moosmann
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy / Q000601:surgery; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D016889:Endometrial Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery; D005260:Female; D006801:Humans; D007258:Informed Consent; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D008297:Male; D020360:Neoadjuvant Therapy / Q000009:adverse effects; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D009367:Neoplasm Staging; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000601:surgery; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery